Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Assets Average: 2022-2025

Historic Assets Average for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Sep 2025 value amounting to $245.3 million.

  • Phathom Pharmaceuticals' Assets Average fell 30.56% to $245.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $245.3 million, marking a year-over-year decrease of 30.56%. This contributed to the annual value of $396.1 million for FY2024, which is 36.90% up from last year.
  • According to the latest figures from Q3 2025, Phathom Pharmaceuticals' Assets Average is $245.3 million, which was down 9.90% from $272.2 million recorded in Q2 2025.
  • Phathom Pharmaceuticals' Assets Average's 5-year high stood at $385.2 million during Q1 2024, with a 5-year trough of $154.4 million in Q1 2023.
  • For the 3-year period, Phathom Pharmaceuticals' Assets Average averaged around $295.3 million, with its median value being $325.4 million (2023).
  • Its Assets Average has fluctuated over the past 5 years, first surged by 149.45% in 2024, then plummeted by 30.56% in 2025.
  • Over the past 4 years, Phathom Pharmaceuticals' Assets Average (Quarterly) stood at $183.4 million in 2022, then soared by 77.46% to $325.4 million in 2023, then grew by 17.60% to $382.7 million in 2024, then plummeted by 30.56% to $245.3 million in 2025.
  • Its Assets Average was $245.3 million in Q3 2025, compared to $272.2 million in Q2 2025 and $336.3 million in Q1 2025.